April 25th 2024
In a collaboration between the University of Oxford, the Ministry of Health in Rwanda, and the Rwanda Biomedical Centre, groundbreaking data on the R21/Matrix-M malaria vaccine, marks a significant shift in the malaria paradigm.
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
View More
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Novartis to Invest $100 Million in Malaria Treatment Research
April 30th 2018The pharmaceutical giant will also launch a program committed to equitable pricing in malaria-endemic countries for new treatments along with expanding pediatric treatment availability and work to strengthen health care systems in 4 African nations.
Read More
New Findings on Zika in Semen May Change Recommendations on Preventing Sexual Transmission
April 26th 2018A recent study sheds light on how long Zika virus can be transmitted through semen following infection, while another study assessed the side effects of Zika infection on infants with post-natal exposure.
Read More
Vaccination Week in the Americas Set to Immunize 70 Million Individuals
April 25th 2018Following outbreaks of measles and yellow fever in parts of Central America, South America, and the Caribbean, PAHO is leading the 16th annual Vaccination Week in the Americas in an effort to vaccinate 70 million individuals against several diseases.
Read More
Federal Government of Nigeria Ensures Free Treatment for Those Affected In Lassa Fever Outbreak
March 22nd 2018As an outbreak of Lassa fever in Nigeria continues to spread, the Coalition for Epidemic Preparedness Innovations is working with Themis Bioscience to develop a vaccine to protect against the virus.
Read More
Yellow Fever Vaccine Needed Before Traveling to Brazil, CDC Warns “Don't Chance It”
March 17th 2018In the wake of news of 10 travelers being infected with yellow fever, 4 of whom have died, the Centers for Disease Control and Prevention (CDC) are urging anyone considering travel to yellow fever endemic regions of Brazil to be vaccinated prior to travel.
Read More
First Tests to Screen for Tick-borne Parasite in Whole Blood and Plasma Approved by FDA
March 7th 2018For use as donor screening tests on samples from individual human donors, the tests will identify antibodies to Babesia microti in human plasma samples and B. microti DNA in human whole blood samples.
Read More
Nigeria Experiencing Biggest Lassa Fever Outbreak To Date
March 2nd 2018An outbreak of Lassa fever in Nigeria that began at the start of the year has now soared to become the country’s biggest outbreak of the virus to date. Nigerian and global health officials are now working together to stop the outbreak.
Read More